LUNG CANCER, NONSMALL CELL
Clinical trials for LUNG CANCER, NONSMALL CELL explained in plain language.
Never miss a new study
Get alerted when new LUNG CANCER, NONSMALL CELL trials appear
Sign up with your email to follow new studies for LUNG CANCER, NONSMALL CELL, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Scientists test safety of new lung cancer combo therapy
Disease control OngoingThis study is checking how safe it is to combine two standard treatments—radiation therapy and immunotherapy drugs—for people with advanced lung cancer that has spread. Researchers are watching 12 patients to see what side effects occur and how the treatment affects their quality…
Matched conditions: LUNG CANCER, NONSMALL CELL
Sponsor: University Health Network, Toronto • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
New Triple-Threat attack on tough lung cancers
Disease control OngoingThis study is testing whether combining three existing drugs—nivolumab, ipilimumab, and nintedanib—is safe and effective for people with advanced non-small cell lung cancer (NSCLC). It will enroll about 66 adults whose cancer has spread and has no curative treatment options. The …
Matched conditions: LUNG CANCER, NONSMALL CELL
Phase: PHASE1, PHASE2 • Sponsor: H. Lee Moffitt Cancer Center and Research Institute • Aim: Disease control
Last updated Mar 30, 2026 14:31 UTC
-
Scientists search for early warning signs in blood to predict lung cancer return
Knowledge-focused OngoingThis study aims to learn if certain markers in the blood can predict whether lung cancer will return after patients finish a standard course of immunotherapy. Researchers will follow 23 patients who have completed about two years of treatment, collecting their blood every few mon…
Matched conditions: LUNG CANCER, NONSMALL CELL
Sponsor: Wake Forest University Health Sciences • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:30 UTC